Login

Clinical Pathways

News

Clinical Decision Tools Within EHR That

Clinical Decision Tools Within EHR That "Nudge" vs "Force" Boost Pathway Compliance, Study Finds

May 30, 2020

NCCN Releases Patient Guidelines for Head, Neck Cancer

May 28, 2020 – Allison Inserro

ASTRO: Amid COVID-19, PPE Shortages, Fewer Visits, and New Ways to Fight Cancer

May 23, 2020 – Mary Caffrey

Collaboration Leads to Clinical Pathways Success for One Illinois Practice

May 21, 2020 – Maggie L. Shaw

Journals

Impact of Next-Generation Sequencing Tests on Clinical Pathways for Cancer Care

February 20, 2020 – Lance Baldo, MD

Clinical Pathways: A Critical Component of Success in Episodes of Care

February 19, 2020 – Lili Brillstein, MPH, and Brian Currie

Clinical Pathways: Reducing Costs and Improving Quality Across a Network

February 19, 2020 – Marcus Neubauer, MD

Conferences

Care Not in Line With Guidelines for HER2-Negative MBC Has Worse Outcomes in Elderly Women

May 23, 2020 – AJMC Staff

Dr Derek Raghavan Explains How Use of Guidelines Can Address Issues of Cost and Variation

May 26, 2018

Dr Derek Raghavan: Evidence-Based Guidelines Will Improve Cancer Outcomes, Reduce Costs

May 09, 2018

Multimedia

Dr Ray Page Outlines Benefits, Challenges of Using Clinical Pathways

Dr Robert Daly Explains the Importance of Updating Pathways With New Data

Study Summaries

Study Summary: Cabozantinib for Advanced and Progressing Hepatocellular Carcinoma

November 09, 2018

Study Summary: Use of Enzalutamide for High-Risk, Nonmetastatic, Castration-Resistant Prostate Cancer (PROSPER)

November 08, 2018

Study Summary: Osimertinib Versus Standard EGFR-TKI Therapy in Patients With EGFR-Mutated Advanced NSCLC and Brain Metastases at Baseline

November 08, 2018

Study Summary: Abemaciclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive, Endocrine-Refractory, Advanced Breast Cancer (MONARCH 2)

September 24, 2018

Study Summary: Abemaciclib as Initial Therapy in Patients With Advanced Breast Cancer (MONARCH 3)

September 24, 2018

Study Summary: Abemaciclib Monotherapy in Patients With Hormone Receptor-Positive, Endocrine-Refractory, Metastatic Breast Cancer (MONARCH-1)

September 24, 2018

ACCOUNTABLE CARE DELIVERY CONGRESS

CONTINUING EDUCATION

Interactive Tools

Managed Care Podcast

Panel Discussions

Information for Reviewers

Information for Authors

Formulary Central

Clinical Study Summaries

Study Summaries

Terms & Conditions

Like Us On Facebook

Follow Us On Twitter

Check us out on LinkedIn

Follow us on Instagram

Subscribe us on YouTube

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.